Prospective, Single-centre, Double-Blind, Randomised, Placebo-controlled Study Evaluating Efficacy of Adalimumab + Methotrextate Compared with Placebo + Methotrexate in Patients with Early Oligoarthritis.

Trial Profile

Prospective, Single-centre, Double-Blind, Randomised, Placebo-controlled Study Evaluating Efficacy of Adalimumab + Methotrextate Compared with Placebo + Methotrexate in Patients with Early Oligoarthritis.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2015

At a glance

  • Drugs Adalimumab (Primary) ; Methotrexate
  • Indications Arthritis
  • Focus Therapeutic Use
  • Acronyms ADEOS
  • Most Recent Events

    • 02 Jul 2015 Status changed from recruiting to completed United Kingdom Clinical Research Network record.
    • 15 Apr 2015 Accrual to date is 91% according to United Kingdom Clinical Research Network record.
    • 11 Mar 2015 Planned End Date changed from 24 Dec 2014 to 30 Jun 2015 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top